Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.13 +0.12 (+2.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Non Operating Interest Expenses (2017 - 2023)

Updated

Adial Pharmaceuticals (ADIL) posted Non Operating Interest Expenses of $14,000 for Q1 2023.

Analysis

Adial Pharmaceuticals (ADIL) Non Operating Interest Expenses (2017 - 2023) Analysis & Trends

For the trailing twelve months through Mar 31, 2023, Non Operating Interest Expenses at Adial Pharmaceuticals was $65,957; for FY2018, it came in at $24,431, down 76.0% from FY2017.

  • In prior years, Adial Pharmaceuticals' Non Operating Interest Expenses was $101,637 in FY2017.
  • The Q1 2023 figure stands as the highest quarterly Non Operating Interest Expenses since Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Adial Pharmaceuticals 18.53 Mn 18.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 14,000.00
Sep 30, 2018 1,068.00
Jun 30, 2018 50,889.00
Mar 31, 2018 23,363.00
Jun 30, 2017 22,826.00
API Access

Adial Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ADIL&period=max&api_key=YOUR_API_KEY